- Home
- OTLK vs RICK Comparison
OTLK vs RICK Comparison
Compare OTLK & RICK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | RICK |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.6M | 214.6M |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | OTLK | RICK |
|---|---|---|
| Price | $0.64 | $30.09 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 21.3M | 57.1K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | ★ 55.91 | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $8,146,123.00 | ★ $144,896,000.00 |
| Revenue This Year | $1,430.98 | $19.32 |
| Revenue Next Year | $173.23 | N/A |
| P/E Ratio | ★ N/A | $184.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $20.76 |
| 52 Week High | $2.54 | $37.30 |
Technical Indicators
Market Signals| Indicator | OTLK | RICK |
|---|---|---|
| Relative Strength Index (RSI) | 32.63 | 55.55 |
| Support Level | $0.19 | $25.10 |
| Resistance Level | $0.94 | $32.00 |
| Average True Range (ATR) | 0.07 | 1.02 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 8.15 | 47.75 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About RICK RCI Hospitality Holdings Inc.
RCI Hospitality Holdings Inc through its subsidiaries, owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, and room rentals.